A critical discovery in cancer investigation is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial malignant suppressor protein is frequently inactivated in various forms of tumors, https://socialmediainuk.com/story28256859/nanobodies-restore-the-p53-protein-a-new-pathway-for-tumor-management